Clinical Trial
Functional Outcomes and Control Using Synchron BCI - Australia
ClinicalTrials.gov12/1/2025·12/01/25🌐 Australia
Summary
This study evaluates the Synchron Stentrode, an endovascular brain-computer interface that is implanted via the jugular vein rather than through open brain surgery. Participants with motor neurone disease (ALS) in Australia will be implanted with the Stentrode to assess its safety and ability to enable brain-controlled digital device operation.
Why it matters
The Stentrode's endovascular approach avoids the risks of open craniotomy, potentially making BCI technology accessible to a much broader patient population. Synchron is one of the most advanced BCI companies with prior clinical data.
#BCI#Neural Interfaces#ALS#Stroke Rehabilitation#Australia#First-in-Human
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in